Leukemia Inhibitory Factor Protects Axons in Experimental Autoimmune Encephalomyelitis via an Oligodendrocyte-Independent Mechanism

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Gresle, Melissa M ^a,b   Alexandrou, Estella ^a,b   Wu, Qizhu ^c   Egan, Gary ^c   Jokubaitis, Vilija ^b   Ayers, Margaret ^a   Jonas, Anna ^b   Doherty, William ^b   Friedhuber, Anna ^a   Shaw, Gerry ^d   Sendtner, Michael ^e   Emery, Ben ^a,b   Kilpatrick, Trevor ^a,b   Butzkueven, Helmut ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR; NEUROFILAMENT PROTEIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HETEROZYGOSITY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATORY CELL; KNOCKOUT MOUSE; MALE; NERVE CELL; NERVE FIBER; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; OPTIC NERVE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL CORD;

ANIMALS; AXONS; CILIARY NEUROTROPHIC FACTOR; CYTOKINE RECEPTOR GP130; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; LEUKEMIA INHIBITORY FACTOR; MICE; MICE, KNOCKOUT; OLIGODENDROGLIA; SIGNAL TRANSDUCTION;

EID: 84867531253     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047379     Document Type: Article

References (36)

1. Bruck W, (2005) The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. Journal of Neurology 252: v3-9.
2. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, et al. (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132: 1175-1189.
3. Bitach A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W, (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123: 1174-1183.
4. Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, et al. (2010) Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. Journal of Neuropathology and Experimental Neurology 69: 1017-1033.
5. Kutzelnigg A, Lucchinetti C, Stadelmann C, Bruck W, Rauschka H, et al. (2005) Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 128: 2705-2712.
6. Compston A, (1996) Remyelination of the central nervous system. Multiple Sclerosis 1: 388-392.
7. Craner M, Newcomb J, Black JA, Hartle C, Cuzner ML, et al. (2004) Molecular changes in neurons in multiple sclerosis: Altered axonal expression of Nav1.2 and Nav1.6 sodium channel and Na+/Ca2+ exchanger. Proceedings of the National Academy of Sciences of the United States of America 101: 8168-8173.
8. Dutta R, McDonough J, Yin X, Peterson J, Chang A, et al. (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Annals of Neurology 59: 478-489.
9. Dutta R, McDonough J, Chang A, Swamy L, Siu A, et al. (2007) Activation of the ciliary neurotrophic factor CNTF signalling pathway in cortical neurons of multiple sclerosis patients. Brain 130: 2566-2576.
10. Mayer M, Bhakoo K, Noble M, (1994) Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120: 143-153.
11. Martinou JC, Martinou I, Kato AC, (1992) Cholinergic differentiation factor (CDF/LIF) promotes survival of isolated rat embryonic motoneurons in vitro. Neuron 8: 737-744.
12. Barbin G, Manthorpe M, Varon S, (1984) Purification of the chick eye ciliary neurotrophic factor. Journal of Neurochemistry 43: 1468-1478.
13. Sendtner M, Gotz R, Holtmann B, Escary JL, Masu Y, et al. (1996) Cryptic physiological trophic support of motorneurons by LIF revealed by double gene targeting of CNTF and LIF. Current Biology 6: 686-694.
14. Sendtner M, Kreutzberg GW, Thoenen H, (1990) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345: 440-441.
15. Barres BA, Jacobson MD, Schmid R, Sendtner M, Raff M, (1993) Does oligodendrocyte survival depend on axons. Current Biology 3: 489-497.
16. Cheema SS, Richards LJ, Murphy M, Bartlett PF, (1994) Leukemia inhibitory factor rescues motorneurons from axotomy-induced cell death Neuroreport. 5: 989-992.
17. Cheema SS, Richards LJ, Murphy M, Bartlett PF, (1994) Leukemia inhibitory factor prevents the death of axotomised secondary neurons in the dorsal root ganglia of the neonatal rat. Journal of Neuroscience Research 37: 213-218.
18. Linker RA, Kruse N, Israel S, Wei T, Seubert S, et al. (2008) Leukemia inhibitory factor deficiency modulates the immune response and limits autoimmune demyelination: a new role for neurotrophic cytokines in neuroinflammation. Journal of Immunology 180: 2204-2213.
19. Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, et al. (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nature Medicine 8: 620-624.
20. Hendricks JA, Slaets H, Carmans S, de Vries HE, Dijkstra CD, et al. (2008) Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. Journal of Neuroimmunology 204: 52-57.
21. Fasnacht N, Muller W, (2008) Conditional gp130 deficient mouse mutants. Developmental Biology 19: 379-384.
22. Butzkueven H, Zhang J-G, Soliu-Hanninen M, Hochrein H, Chionh F, et al. (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nature Medicine 8: 613-619.
23. Kuhlmann T, Remington L, Cognet I, Bourbonniere L, Zehntner S, et al. (2006) Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelits. Neurobiology 169: 584-598.
24. Haroon F, Drogemuller K, Handel U, Brunn A, Reinhold D, et al. (2011) Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation. Journal of Immunology 186: 6521-6531.
25. Emery B, Cate H, Marriott M, Merson T, Binder MD, et al. (2006) Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proceedings of the National Academy of Sciences of the United States of America 103: 7859-7864.
26. Gow A, Friedrich VL, Lazzarini RA, (1992) Myelin basic protein gene contains separate enhancers for oligodendrocyte and schwann cell expression. Journal of Cell Biology 119: 605-616.
27. Betz UAK, Bloch W, Van Den Broek M, Yoshida K, Taga T, et al. (1998) Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. Journal of Experimental Medicine 188: 1955-1965.
28. Gresle MM, Shaw G, Jarrott B, Alexandrou EN, Friedhuber A, et al. (2008) Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis. Journal of Neuroscience Research 86: 3548-3555.
29. Soilu-Hanninen M, Epa R, Shipham KA, Butzkueven H, Bucci T, et al. (2000) Treatment of experimental autoimmune encephalomyelitis with antisense oligonucleotides against the low affinity neurotrophin receptor. Journal of Neuroscience 59: 712-721.
30. Butzkueven H, Emery B, Cipriani T, Marriott M, Kilpatrick TJ, (2006) Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 53: 696-703.
31. Wu Q, Butzkueven H, Gresle M, Kirchhoff F, Friedhuber A, et al. (2007) MR diffusion changes correlate with ultra-structurally defined axonal degeneration in murine optic nerve. Neuroimage 37: 1138-1147.
32. Sendtner M, Gotz R, Holtmann B, Escary JL, Masu Y, et al. (1996) Cryptic physiological trophic support of motorneurons by LIF revealed by double gene targeting of CNTF and LIF. Current Biology 6: 686-694.
33. Kerr BJ, Patterson PH, (2005) Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia 51: 73-79.
34. Lee TI, Yang CS, Fang KM, Tzeng SF, (2009) Role of ciliary neurotrophic factor in microglial phagocytosis. Neurochemical Research 34: 109-117.
35. Cao W, Yang Y, Wang Z, Liu A, Fang L, et al. (2011) Leukemia Inhibitory Factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. Immunity 35: 273-284.
36. Menkhorst E, Zhang JG, Sims NA, Morgan PO, Soo PY, et al. (2011) Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice. PLoS One 6: e19665.